While Guardant Health Inc has underperformed by -0.92%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, GH rose by 237.84%, with highs and lows ranging from $112.43 to $29.91, whereas the simple moving average jumped by 79.01% in the last 200 days.
On December 02, 2025, Morgan Stanley started tracking Guardant Health Inc (NASDAQ: GH) recommending Overweight. A report published by Wolfe Research on September 25, 2025, Upgraded its rating to ‘Outperform’ for GH. Wells Fargo also rated GH shares as ‘Overweight’, setting a target price of $72 on the company’s shares in an initiating report dated September 22, 2025. Mizuho Initiated an Outperform rating on April 10, 2025, and assigned a price target of $55. Barclays initiated its ‘Overweight’ rating for GH, as published in its report on January 23, 2025. Guggenheim’s report from June 28, 2024 suggests a price prediction of $36 for GH shares, giving the stock a ‘Buy’ rating. Jefferies also rated the stock as ‘Buy’.
Analysis of Guardant Health Inc (GH)
Further, the quarter-over-quarter increase in sales is 38.50%, showing a positive trend in the upcoming months.
To gain a thorough understanding of Guardant Health Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of -4584.47% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 3.12, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and GH is recording an average volume of 2.65M. On a monthly basis, the volatility of the stock is set at 5.17%, whereas on a weekly basis, it is put at 4.68%, with a loss of -0.64% over the past seven days. Furthermore, long-term investors anticipate a median target price of $101.73, showing decline from the present price of $103.21, which can serve as yet another indication of whether GH is worth investing in or should be passed over.
How Do You Analyze Guardant Health Inc Shares?
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 4.04%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 96.59% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
